After decades of grueling research and investment, immunotherapy is now poised to revolutionize the treatment of an array of conditions affecting millions of people around the world. Some cancer patients – who only a few years ago would have faced certain death – are now achieving complete remissions after undergoing immunotherapy. Clinical trials are revealing crucial roles for immunotherapies in combating conditions from rheumatoid arthritis to Alzheimer’s to infectious disease, including the COVID-19 pandemic. Breakthroughs are happening every day, and we may only be at the beginning of this wave of innovative treatment.
This report outlines the key pillars to unlock the promise of immunotherapy and the challenges faced by stakeholders in each area. It concludes with a number of recommendations for governments, regulators, communities, businesses and institutions to maximize the benefits of immunotherapy. Together, we can harness this innovation to improve the health and wellbeing of millions of families worldwide.